Riskpilot← Back to searchSign inGet full accessAPEXKLINIKKEN TERAPISENTER AS
ASActiveOrg 923484523Fyrstikkalléen 3B, 0661 OsloPhysiotherapy activities · NACE 8695Est. 20192 employeeswww.apexklinikken.no
Revenue 2024
NOK 10,7M
-10% vs 2023
EBITDA margin
-0.2%
-101% vs 2023
Equity ratio
39.4%
Financial strength
Net profit 2024
NOK -19K
-101% vs 2023
| Revenue | NOK 10,7M | -10% |
| EBITDA | NOK -16K | -101% |
| Net profit | NOK -19K | -101% |
| Total assets | NOK 3M | -29% |
| Equity | NOK 1,2M | -30% |
| Employees | 2 | — |
Legal name
APEXKLINIKKEN TERAPISENTER AS
Org number
923484523
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
30. september 2019
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Helse, fysioterapi, legetjenester, kiropraktikk, psykologtjenester, personlig trening, massasjeterapi, fysikalsk institutt, treningssenter.
Address
Fyrstikkalléen 3B, 0661 Oslo
Phone
+4722199070
Email
kontakt@apexklinikken.no
Website
www.apexklinikken.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 10 032 | 10 982 | 12 647 | 11 912 | 10 723 |
| Staff expenses | −966 | −1 254 | −1 531 | −964 | −395 |
| EBITDA | 2 009 | 1 614 | 2 246 | 1 726 | −16 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 2 009 | 1 614 | 2 246 | 1 726 | −16 |
| Net financials | −76 | −117 | −9 | −3 | −3 |
| Profit before tax | 1 933 | 1 497 | 2 237 | 1 723 | −19 |
| Tax | 437 | 359 | 487 | 404 | −0 |
| Net profit | 1 496 | 1 138 | 1 750 | 1 319 | −19 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 338 | 2 384 | 4 469 | 4 186 | 2 985 |
| Equity | 34 | 391 | 971 | 1 672 | 1 176 |
| Long-term debt | 714 | 384 | 94 | 0 | 0 |
| Short-term debt | 2 591 | 1 608 | 3 405 | 2 514 | 1 809 |
| Total debt | 3 304 | 1 993 | 3 498 | 2 514 | 1 809 |
EBITDA margin
-0.2%
This company
15.8%
Market median
-101% vs market
20202024
Equity ratio
39.4%
This company
38.2%
Market median
+3% vs market
20202024
Return on equity
-1.6%
This company
18.4%
Market median
-109% vs market
20202024
Net profit margin
-0.2%
This company
8.1%
Market median
-102% vs market
20202024
Asset turnover
3.59×
This company
1.12×
Market median
+221% vs market
20202024
Debt / equity
1.54×
This company
0.62×
Market median
-148% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MM Chief Executive Officer | Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2023 | |
| Chairman | 2025 | |
| Former (1) | ||
| Chairman | 2019 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nord-Varhaug Holding As
APEXKLINIKKEN TERAPISENTER AS Board members of APEXKLINIKKEN TERAPISENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marthe Mari Jørstad | Chief Executive Officer | 0 companies |
| Aud Nord-Varhaug | Chairman | 0 companies |
| Eirik Sæves | Chairman | 0 companies |
| Kjetil Christiansen Nord-Varhaug | Chairman | 0 companies |